Efforts focused on four areas: access and health equity, workforce and DE&I, community impact and the environment CAMBRIDGE, ...

May 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced publication of its 2023 Corporate Responsibility Report detailing progress on the company's commitment to making responsible ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The company’s shares closed yesterday at $52.05. Abrahams covers the Healthcare sector, focusing on stocks such as SAGE Therapeutics, Biogen, and Gilead Sciences. According to TipRanks, Abrahams has ...

From 1984-2012, he was a research scientist in the immunobiology discovery group at the biotech firm Biogen in Cambridge Mass. His research interests are centered on the tumor necrosis factor family ...

Mattke reported receiving grants from Genentech for a research contract with USC during the conduct of the study; personal ...

Moderna (MRNA) is set to release its Q1 earnings results, with analysts expecting a significant decline in revenue.

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a ...